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ABSTRACT 27 
Background: Peristomal skin complications are a common problem for ileostomates.  A research group 28 
at the University of Limerick has developed a novel ostomy barrier ring that aims to help address this 29 
problem. The novel barrier ring seeks to reduce peristomal moisture-associated skin damage (MASD) 30 
by introducing an additional non-absorbent layer in a spout-shaped profile, to assist effluent drainage 31 
more completely into the ostomy bag, thereby preventing the effluent contacting the skin.  32 
Purpose: This feasibility study aimed to evaluate the performance of a novel barrier ring with an 33 
assisted flow mechanism by assessing changes in ileostomates’ skin condition and their perception of 34 
comfort, security, handling and discretion. 35 
Subjects and Settings: Twenty ileostomates aged 18yrs or older who had their ileostomy for six 36 
months or more were recruited for this study. Of the twenty participants, eight did not complete the 37 
study. The primary reason for dropouts concerned compatibility issues of some convex bags with the 38 
novel barrier ring.  39 
Design: Single arm, open-labelled feasibility study. 40 
Methods: Each participant was required to use the novel barrier ring along with their normal ostomy 41 
bag for a period of six weeks. Change in skin condition over the six-week period was assessed using 42 
the Ostomy Skin Tool (OST). Participants’ perception of the novel skin barrier’s comfort, security, 43 
handling and discretion was also recorded on a 10-point scale, where participants would offer a low 44 
score if their experience was negative and a higher score if their experience was positive. Participants 45 
changed pouches and barrier rings at their own discretion. For participants who completed the study, 46 
average skin condition and median ratings of comfort, security, handling and discretion at six weeks 47 
were compared to the same measurements at the beginning of the study.  48 
Results: Twelve (60%) of the 20 participants completed the study. For those who completed, mean 49 
score on the OST decreased from 6.2 (SD 1.90) at baseline to 3.4 (SD 1.73) at 6 weeks, a mean 50 
reduction of 2.8 (95% confidence interval -1.6 to -3.9, p<0.001). Skin condition of nine participants 51 
improved, with three participants having no change. All participants who completed the study rated 52 
comfort, handling, security and discretion highly (median of 10 at baseline and six weeks). 53 
Conclusions: Data from this study indicate the novel ostomy barrier ring may reduce levels of 54 
peristomal MASD in persons living with an ileostomy, though a more extensive trial with a control 55 
group is recommended.   56 
1 INTRODUCTION 57 
Peristomal skin complications are a common problem, particularly for people with ileostomies, with 58 
prevalence rates of 66% reported in literature.1 Peristomal skin complications are indicated to account 59 
for more than one in three visits to ostomy nurses.2 Peristomal Moisture–Associated Skin Damage 60 
(MASD) is the most common form of peristomal skin damage3 and occurs when excessive moisture in 61 
urine, stool and wound exudate leads to inflammation of the skin, with or without erosion or 62 
secondary cutaneous infection.4 Jemec et al. reported that peristomal MASD accounted for 35% of 63 
skin complications in their study.1  It is proposed that the use of standard hydrocolloid ostomy barrier 64 
rings for the prevention of peristomal MASD, though partially effective, does not appear to offer 65 
complete protection of the skin. We further propose that the incomplete barrier offered by current 66 
ostomy barrier rings may be due to the absorbency of the hydrocolloid material used in these 67 
products.  68 
The current study seeks to establish the feasibility of a novel ostomy barrier ring design through a six-69 
week open labelled, single-arm study.  Participants’ skin condition was recorded at the beginning of 70 
the study, and again at six weeks, and changes in the average skin condition were measured in order 71 
to establish potential benefits for the user’s skin. In addition, participants’ perception of the novel 72 
device was rated through scales from 1 to 10 measuring comfort, security, handling and discretion. 73 
These metrics were anticipated to offer researchers an indication of whether the device would be 74 
adopted by ostomates outside of a trial setting.  75 
 76 
2 METHOD 77 
Potential study participants were recruited from the stoma care nurse’s outpatient list at the 78 
University Hospital Limerick. Inclusion criteria were adults aged 18 years and older with an end or loop 79 
ileostomy created more than six months prior to study participation, intact peristomal skin, and being 80 
capable of independently changing their pouching system or able to change their system with a 81 
caregiver’s assistance. Participants currently using a commercially available ostomy barrier ring were 82 
eligible for inclusion but were required to stop using their regular barrier ring for the duration of the 83 
study. Exclusion criteria were participants who had a DET score of 10 or more, or persons with an 84 
enterocutaneous fistula. 85 
Two sizes of the novel barrier ring were developed and used during the study with inner diameters of 86 
26mm or 34mm for different sizes of ileostomy. These sizes were established through prior fit-testing 87 
research, whereby various prototype sizes were manufactured and tested on prosthetic stomas. It 88 
was ultimately determined that, because of the flexibility of the device, a 26mm size could fit stomas 89 
from 18mm to 28mm in diameter, and a 34mm size could fit stomas from 29mm to 42mm in diameter. 90 
As such, two sizes were determined to suffice.  91 
The study was conducted at the University Hospital Limerick in collaboration with the School of Design 92 
in the University of Limerick, Ireland. Ethical approval was granted through the Health Products 93 
Regulatory Authority and the University Hospital Limerick.  94 
Participants wore a novel ostomy barrier ring (the OSTOFORMTM Mouldable Seal with FLOWASSISTTM 95 
Protection) that has been developed by the Ostoform Research Group in the University of Limerick 96 
comprising a hydrocolloid ring and a flexible, non-absorbent component, designed to prevent effluent 97 
contacting the skin (Figure 1). Commercially available barrier rings are primarily circular, but the novel 98 
device comprises a broken circle so that the user can wrap it around their stoma shape for a complete 99 
fit and seal. The non-absorbent spout is proximal to the stoma, designed to enable effluent to flow 100 
more efficiently into the bag, protecting the skin inferior to the stoma. An added feature of the novel 101 
device is that its non-absorbent component acts as a handling tab, enabling the user to hold the barrier 102 
ring while positioning it with little effort. In initial user studies this appears to make it easier for the 103 
user to accurately position the barrier ring around their ileostomy. 104 
 105 
Instruments 106 
The Ostomy Skin Tool (OST) is a validated peristomal skin assessment tool that scores skin condition 107 
in three domains: Discoloration (D), Erosion (E) and Tissue Overgrowth (T), called the DET scoring 108 
system.1 Within each domain, both the area of peristomal skin affected and the severity of the skin 109 
changes are scored. The area affected is assigned a score between 0 and 3, and the severity is scored 110 
between 0 and 2. Therefore, each of the three domains has a cumulative score between 0 and 5, and 111 
their scores are summed to give a total DET score of 0 to 155. Total DET score of < 4 is classified as mild 112 
skin complications, 4-6 as moderate and >=7 as severe. DET scores were collected by a research nurse 113 
who was trained in the use of the OST and in ostomy pouch changing techniques by a clinical nurse 114 
specialist in ostomy care in the University Hospital Limerick.  115 
Secondary outcome measures of comfort, security, handling and discretion were gathered on non-116 
validated 10-point-scales, whereby the participant was asked, by the same research nurse, to rate 117 
their perception of each. A score of 1 was considered to be the most negative result (for example, very 118 
uncomfortable) and a score of 10 was considered to be the most positive result (very comfortable).  119 
Study Procedures 120 
Participants were evaluated at three time intervals: baseline (T=0), after 2 weeks (T=2) and at 6 weeks 121 
(T=6). Participants wore the novel barrier ring for the 6-week period, along with their own ostomy 122 
bags, and returned to their standard practice upon completion of the 6-week study.   123 
Additional measurements recorded by the research nurse at baseline included stoma height and 124 
diameter, and waist circumference measured while the participant stood. These measurements were 125 
collected to help understand any potential challenges of certain stoma types with the new device 126 
design. For example, it would prove useful to know if the device worked with flush or retracted stomas. 127 
In the case of a loop ileostomy, the mucus stoma height diameter was recorded. A summary of the 128 
study measurements and time points is given in Figure 2. 129 
The novel barrier ring was developed with potential risks or serious adverse events considered and 130 
risk analyses were regularly performed with procedures in place for reporting any serious adverse 131 
events.  132 
[Insert Figure 2 about here] 133 
  134 
Statistical Analysis 135 
Categorical variables were summarised using counts and percentages. Numeric variables were tested 136 
for normality and summarised using mean (SD) for normally distributed variables or median 137 
(minimum, maximum) for skewed data. Changes in total DET scores and domain scores from baseline 138 
to six weeks were tested for normality and a paired t-test was used to test for a statistically significant 139 
mean change over time. A 95% confidence interval for the mean change was calculated. Pearson’s 140 
correlation coefficient was used to measure the strength of the association between change in DET 141 
score and baseline DET score. Characteristics of completers and non-completers were compared using 142 
a Mann-Whitney test for skewed distributions, independent samples t-test for normally distributed 143 
distributions and chi-squared test for categorical variables. A 5% level of significance was used for all 144 
tests. SPSS for Windows Version 22 was used for all analyses. 145 
 146 
3 RESULTS 147 
3.1 Analysis of participants who completed the study 148 
Of the 20 participants recruited, 12 (60%) completed the study. Of the completers, there was a 45% 149 
reduction in the average DET score from baseline to week six. The mean age of the completers was 49 150 
years (SD 11.7, range 30 - 65 years). Seven (58%) were female. Eight (66%) had an end ileostomy and 151 
four (33%) had a loop ileostomy. Four completers (33%) had already been using commercially available 152 
hydrocolloid barrier rings  before the study. Physical characteristics of non-completers and for the 12 153 
completers are summarised in Table 1. Non-completers were more likely to be male, older, with larger 154 
waist circumferences and higher baseline DET scores than those who completed the study (Table 1). 155 
 [Insert Table 1 about here] 156 
Eight (40%) of the 20 participants who consented to participate dropped out before week twelve: Six 157 
left before week 2 and two between week 2 and 6. Reasons for dropping out are summarised in Table 158 
2.  159 
[Insert Table 2 about here] 160 
3.1.1 Primary outcome: DET score 161 
The mean DET score at baseline for the 12 completers was 6.2 (SD 1.90). Skin condition of one 162 
participant was rated mild (DET < 4), 6 moderate (DET 4-6 category) and 5 severe (DET >=7).  163 
After six weeks, the mean DET score for the 12 completers was 3.4 (SD 1.73). Figure 3 gives the 164 
distribution of changes in DET score from baseline to 6 weeks with 9 (75%) of the 12 completers having 165 
a decrease in DET scores over time ranging from a decrease of 2 to 5 and three (25%) experiencing no 166 
change in DET score. At six weeks, skin condition of eight completers were rated mild (DET < 4), 3 167 
moderate (DET 4-6 category) and one severe (DET >=7).  168 
The mean change over time represents a decrease of 2.75 in DET score (95% confidence interval -1.6 169 
to -3.9, p<0.001). The change in DET score was strongly correlated with baseline DET score (r=-0.57, 170 
p=0.06) with higher baseline scores associated with greater reductions. 171 
The mean reduction of 2.5 (SD 1.92) in DET score over time for those with loop ileostomies (n=4) was 172 
comparable to the mean reduction of 2.9 (SD 1.89) in those with end ileostomies (n=8) (95% 173 
confidence interval for the difference in means  -2.19 to 2.99, Figure 3). All four participants who had 174 
been previously using a barrier ring had a reduction in baseline DET score over time with a mean 175 
reduction of 4.25 (95% confidence interval 3.45 to 5.04)  176 
 177 
[Insert Figure 3 about here] 178 
 179 
Tissue overgrowth was scored zero for both area and severity for all 12 completers at all three time 180 
points. As a result, changes in DET reflected the domains of discoloration and erosion. Discoloration 181 
area reduced from a baseline mean of 2.25 (SD 0.75) to 1.75 (SD 0.75) with a mean reduction of -0.50 182 
(95% confidence interval -1.20 to 0.19, p=0.14). Discoloration severity reduced from a baseline mean 183 
of 1.33 (SD 0.49) to mean 1.08 (SD 0.29) with a mean reduction of -0.25 (95% confidence interval -184 
0.54 to 0.04, p=0.08) (Table 3).  185 
 186 
Erosion area reduced from a baseline mean of 1.5 (SD 0.15) to 0.30 (SD 0.65). Erosion severity reduced 187 
from a baseline mean of 1.08 (SD 0.51) to mean 0.25 (SD 0.45) (Table 3). There was a highly significant 188 
(p<0.001) reduction in total erosion score (area + severity) from baseline to six weeks, with 8 189 
participants eradicating erosion. 190 
 191 
[Insert Table 3 about here] 192 
 193 
3.1.2 Secondary outcomes 194 
For the 12 completers, their ratings of security, handling, comfort and discretion are summarised in 195 
Table 4. The median scores were high (≥9.5) at each time point.  196 
 197 
Four of the 12 completers reported leakage prior to using the device. At six weeks, one of these no 198 
longer reported leakage. There were two records of adverse events. One patient with ulcerative 199 
colitis was diagnosed with pouchitis after presenting to hospital with lower abdominal pain, rectal 200 
bleeding and bleeding through the stoma. The principal investigator (JCC) deemed the patient’s 201 
adverse event was not product related. The second patient with an adverse event was admitted to 202 
hospital presenting with right sided abdominal pain, which was diagnosed with cholecystitis. The 203 
event was deemed not to be product related by the research nurse (EC) and the principal 204 
investigator (JCC). In both instances the principal investigator deemed there was no safety risk to the 205 
patients so they remained in the study.  206 
 [Insert Table 4 about here] 207 
 208 
 209 
4 DISCUSSION 210 
 211 
The novel ostomy device with a non-absorbent component has been introduced to prevent absorption 212 
of acidic effluent. It is proposed that this feature of the design is one important reason why 213 
participants who had been wearing a barrier ring before commencing the study, experienced an 214 
improvement in skin condition.  215 
 216 
Of the twelve participants who completed the study, four had loop ileostomies. The change in skin 217 
condition for these four participants was comparable to those with end ileostomies, giving evidence 218 
that the novel barrier ring may be useful for both types of stoma.  219 
 220 
Participants rated the handling of the product highly with a median score of 10 at all time points. An 221 
added feature of the spout design was that it could be used as a handling tab, enabling users to 222 
position the barrier ring underneath the stoma during use, eliminating the need to touch the 223 
hydrocolloid. The research nurse observed that participants were inclined to use the device in this 224 
manner. This means that the barrier ring’s hydrocolloid surface need not touch and stick to the user’s 225 
fingers, potentially improving the positioning accuracy and therefore the quality of seal around the 226 
stoma. A potential concern for the protruding spout is whether it would be visible underneath the 227 
user’s clothes, but ratings of discretion were also high (median score of 10 at all time points), 228 
suggesting that the spout protrusion and the overall design were sufficiently discreet.  229 
 230 
Eight of the 20 participants did not complete the study with non-completers tending to be older, with 231 
a higher baseline DET score and larger waist circumference. It is proposed that ostomates with a larger 232 
waist circumference and potentially excess tissue can be more difficult cases to manage. Trying a new 233 
accessory can require some changes in practice for the user, which may prove more challenging for 234 
older users who have become accustomed to using their current pouching system. For three 235 
participants that opted out, the use of their convex bag in combination with the novel barrier ring 236 
proved challenging. Because the hydrocolloid in the novel barrier ring is thick (3mm), combining a 237 
convex bag with a thick protective ring can result in accumulated peristomal pressure. Convex bags 238 
already place some pressure on the peristomal skin and the introduction of additional material to the 239 
peristomal area could further increase pressure to this area, potentially causing discomfort. In one 240 
case the participant used an ostomy belt, which, again, was suspected to have contributed to 241 
increased pressure. Further product development could include a thinner version of the novel barrier 242 
ring for use with convex bags.  243 
 244 
Limitations 245 
A single arm study was conducted. Finding a control group of participants who had a uniform pouching 246 
system, working from a single site study, would have been difficult to achieve because of the vast 247 
range of ostomy products available. As such, it was considered more appropriate, as an early feasibility 248 
study, to take each participant’s skin condition at the beginning, and assess for changes in skin 249 
condition over time, without the need for a control group, though challenges in measuring efficacy 250 
through this study design are acknowledged. It is proposed that future studies with larger sample sizes 251 
should consider a crossover trial or the inclusion of a control group. 252 
The intra- and inter-examiner reliability of the OST has been previously demonstrated (Jemec et al. 253 
2010). In the current study, data were collected at all time points by the same trained research nurse 254 
to avoid inter-observer variability. However, a limitation of the OST is that, rather than measuring the 255 
level of peristomal MASD, it measures the overall peristomal skin condition. Therefore, other factors, 256 
such as mechanical dermatitis and allergies may also affect the DET score. To the researchers’ 257 
knowledge, at the time of data collection, no validated measurement tool specifically for peristomal 258 
MASD is available. 259 
5 Conclusions 260 
This was an initial feasibility study of a novel ostomy barrier ring that was developed  with the aim of 261 
managing and preventing peristomal skin complications. The novel barrier ring’s non-absorbent spout 262 
component for assisted flow aims to minimise the amount of effluent contacting the ostomate’s skin, 263 
and initial participant data from this 6-week feasibility study suggests the basic principle of design may 264 
help in managing peristomal MASD. Furthermore, the participant ratings relating to the usability of 265 
the novel barrier ring scored highly. A trial with a larger participant sample size is recommended in 266 
order to gain more definitive evidence of device efficacy. 267 
 268 
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Figure 1: Illustration of the novel seal, in profile (Left) and in cross-section appearance (Right). 
 
Figure 2 Flow diagram depicting the study design and data collection points.  
 
 
                                                                                                                                                                                    
  
Figure 3. Histogram of change in DET score (baseline to 6 weeks) (n=12) 
 





Completers (n=12) P-value 
Mean age in years (range) 59 (41, 77) 49 (30, 65) 0.09 
Male (n, %) 6 (75%) 5 (42%) 0.20 
End ileostomy (n, %) 6 (75%) 8 (67%) 1.00 
Median stoma height (Faecal Fistula) 
(range) 
21.5 (4, 29) 19.5 (11, 40) 0.65 
Median stoma height (Mucus Fistula) 
(range)1 
18 (16, 20) 6.5 (1, 37) - 
Median waist circumference (range) 1080 (690, 1430) 900 (730, 1160) 0.07 
Median baseline DET score (range) 8 (4,9) 6 (2,9) 0.38 
1 n=2 for dropouts and n=4 for completers 







                                                                                                                                                                                    
 
Table 2: Reasons for non-completion 
Leakage due to scissor puncture in convex bag. 
Use of the incorrect indicated opening size. 
Too much pressure with hernia belt. 
Inconclusive. Sore peristomal skin with no leaks experienced. 
Convex bag opening size restriction was too small for correct use of product. 
Difficult mucus stoma position. Mucus emptying at 1 o'clock position. 
Participant not using the correct indicated opening size 
Non-compliant patient with incorrect use of paste with product and unwell due 
to Chrohn’s flare up. 
 
 









Mean (SD) at baseline 2.25 (0.75) 1.33 (0.49) 1.50 (0.80) 1.08 (0.51) 
Mean (SD) at 6 weeks 1.75 (0.75) 1.08 (0.29) 0.33 (0.65) 0.25 (0.45) 
Mean difference over time 













Table 4. Median (min, max) participant rating for security, handling, comfort and discretion (n=12) 
  Baseline Week 2 Week 6 
Security 10 (5, 10) 9.5 (5, 10) 10 (6, 10) 
Handling 10 (5, 10) 10 (8, 10) 10 (7, 10) 
Comfort 10 (6, 10) 10 (8, 10) 10 (7, 10) 
Discretion 10 (7, 10) 10 (7, 10) 10 (6, 10) 
 
 
 
 
